...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Stimulation of thrombin- and plasmin-mediated activation of thrombin-activatable fibrinolysis inhibitor by anionic molecules
【24h】

Stimulation of thrombin- and plasmin-mediated activation of thrombin-activatable fibrinolysis inhibitor by anionic molecules

机译:阴离子分子刺激凝血酶和纤溶酶介导的凝血酶可激活的纤溶抑制剂的激活

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Thrombin-activatable fibrinolysis inhibitor (TAFI) is a proenzyme that, once activated, attenuates fibrinolysis by removing C-terminal lysine residues from partially degraded fibrin. TAFI can be activated by thrombin or plasmin via a cleavage at Arg92 that removes the activation peptide from the enzyme, TAFIa. Thrombomodulin enhances thrombin-mediated TAFI activation and glycosaminoglycans enhance plasmin-mediated TAFI activation. The aim of this study was to investigate whether there are other anionic molecules that function as a cofactor for thrombin- or plasmin-mediatecl TAFI activation.
机译:背景:凝血酶可激活的纤维蛋白溶解抑制剂(TAFI)是一种酶,一旦被激活,就会通过从部分降解的纤维蛋白中去除C端赖氨酸残基来减弱纤维蛋白溶解。凝血酶或纤溶酶可以通过在Arg92处裂解来激活TAFI,该裂解会从酶TAFIa中去除激活肽。血栓调节蛋白增强凝血酶介导的TAFI活化,而糖胺聚糖增强纤溶酶介导的TAFI活化。这项研究的目的是调查是否还有其他阴离子分子可作为凝血酶或纤溶酶介导的TAFI激活的辅助因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号